Core Viewpoint - A class action lawsuit has been filed against Plug Power Inc. and certain officers for alleged violations of federal securities laws during the Class Period from January 17, 2025, to November 13, 2025, seeking damages for misleading statements regarding the company's business and operations [1][7]. Group 1: Lawsuit Details - The class action was filed in the United States District Court for the Northern District of New York, seeking to recover damages for all persons and entities that purchased Plug Power securities during the specified Class Period [1]. - Investors have until April 3, 2026, to request appointment as Lead Plaintiff for the class [2]. Group 2: Company Operations - Plug Power provides hydrogen fuel cell turnkey solutions for electric mobility and stationary power markets in North America and Europe, including hydrogen storage and production equipment [4]. - The company has been committed to building a network of hydrogen production plants across the United States [4]. Group 3: Financial Developments - In January 2025, Plug Power announced a $1.66 billion loan guarantee from the U.S. Department of Energy's Loan Program to finance the construction of up to six projects for producing and liquefying zero- or low-carbon hydrogen [5]. - Approval and funding of the DOE Loan were contingent on meeting specific conditions, including technical and performance-related requirements [6]. Group 4: Allegations of Misleading Statements - The Complaint alleges that Plug Power's executives made materially false and misleading statements about the availability of funds from the DOE Loan and the company's ability to construct necessary hydrogen production facilities [7]. - The lawsuit claims that the company was likely to pivot towards less ambitious projects, contradicting earlier public statements [7]. Group 5: Executive Changes and Market Reaction - On October 7, 2025, Plug Power announced the resignation of CEO Andrew Marsh and President Sanjay Shrestha, with Jose Luis Crespo appointed to both roles, which raised concerns about the company's stability [8]. - Following the announcement of executive changes, Plug Power's stock price fell by 6.29% to close at $3.87 per share [9]. - On November 10, 2025, the company reported financial results and announced a suspension of activities under the DOE loan program, leading to a further decline in stock price [10]. - The stock price dropped by 17.58% over two trading sessions after news of the suspension of plans to construct hydrogen facilities [12].

Core Viewpoint - A class action lawsuit has been filed against Ramaco Resources, Inc. for allegedly misleading investors regarding the development progress of its projects, particularly the Brook Mine in Wyoming [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased Ramaco securities between July 31, 2025, and October 23, 2025 [1][2]. - Investors have until March 31, 2026, to seek appointment as lead plaintiff representative of the class [2]. Group 2: Allegations - The complaint alleges that Ramaco overstated development progress at the Brook Mine, which was described as a "hoax" and a "Potemkin Mine" by Wolfpack Research [3]. - The report indicated that no significant mining activity had occurred since the groundbreaking, supported by drone footage and site visits [3]. Group 3: Market Reaction - Following the news of the lawsuit, Ramaco's stock price dropped by $3.81, nearly 10%, closing at $36.01 per share with unusually high trading volume [4].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation for allegedly making misleading statements and failing to disclose material adverse facts regarding its business performance during the specified Class Period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired Integer securities from July 25, 2024, to October 22, 2025 [1][2]. - Investors have until February 9, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Allegations Against the Company - The complaint alleges that Integer overstated its competitive position and did not adequately disclose a deterioration in sales of its electrophysiology devices [3]. - The lawsuit claims that the company mischaracterized its growth drivers [3]. Group 3: Impact of Disclosures - The truth about the company's performance began to emerge on October 23, 2025, when Integer reduced its sales guidance and disclosed an expected sales decline [3]. - Following these disclosures, Integer's stock price fell by $35.22 per share, a decline of over 32% in one trading day [3].

Core Viewpoint - The Varonis Systems, Inc. is facing a class action lawsuit due to allegations of misleading investors regarding its revenue outlook and growth potential, leading to significant stock price declines following disappointing financial results [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Molchanov v. Varonis Systems, Inc. and involves purchasers of Varonis common stock from February 4, 2025, to October 28, 2025 [1]. - Investors have until March 9, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Varonis and its executives violated the Securities Exchange Act of 1934 by providing false information about the company's financial health [3]. Group 2: Allegations Against Varonis - The lawsuit claims that Varonis misrepresented its ability to maintain revenue growth and downplayed risks associated with seasonality and macroeconomic factors [3]. - On October 28, 2025, Varonis reported third-quarter results that significantly missed projections, leading to a lowered full-year guidance [4]. - Following the release of these disappointing results, Varonis' stock price fell nearly 49% [4]. Group 3: Legal Process and Representation - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Varonis stock during the class period to seek lead plaintiff status [5]. - The lead plaintiff will represent the interests of all class members and can choose a law firm for litigation [5]. - Participation as a lead plaintiff does not affect an investor's ability to share in any potential recovery from the lawsuit [5].

SAN FRANCISCO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing an updated notice to investors in BellRing Brands, Inc. (NYSE: BRBR) regarding the March 23, 2026, lead plaintiff deadline accusing BellRing and certain of BellRing’s top executives of securities fraud. CLICK HERE TO SUBMIT YOUR BRBR LOSSES NOW The suit alleges Defendants misled investors about the true drivers of BellRing’s 2025 sales growth. The truth emerged over a series of disclosures revealin ...

Core Viewpoint - Fermi Inc. is facing a class action lawsuit due to alleged misleading statements and failures to disclose critical information during its IPO and subsequent trading period, leading to significant stock price declines [1][3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Lupia v. Fermi Inc. and was filed in the Southern District of New York, charging Fermi and its executives with violations of the Securities Act of 1933 and the Securities Exchange Act of 1934 [1][3]. - Investors who purchased Fermi common stock during the IPO or between October 1, 2025, and December 11, 2025, can seek appointment as lead plaintiff by March 6, 2026 [1][6]. - The lawsuit alleges that Fermi overstated tenant demand for its Project Matador campus and failed to disclose reliance on a single tenant's funding commitment, which posed a significant risk [3][4]. Group 2: Financial Impact - Following the announcement that the first tenant for Project Matador terminated a $150 million funding agreement, Fermi's stock price dropped nearly 34% [4]. - The stock price has since fallen to as low as $8.59 per share, representing a 59% decline from the IPO price of $21.00 per share [5]. Group 3: Company Background - Fermi Inc. is described as an energy and AI infrastructure company, having sold 37,375,000 shares at $21.00 each during its October 2025 IPO [2][3]. - Robbins Geller Rudman & Dowd LLP, the law firm representing the investors, is noted for its significant recoveries in securities-related class action cases, having recovered over $2.5 billion for investors in 2024 alone [7].

Core Viewpoint - Richtech Robotics Inc. is facing a class action lawsuit for allegedly misleading investors about its relationship with Microsoft, which has resulted in significant stock price declines [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Diez v. Richtech Robotics Inc. and is filed in the District of Nevada [1]. - The lawsuit alleges that Richtech Robotics falsely claimed a commercial relationship with Microsoft during the class period from January 27, 2026, to January 29, 2026 [3]. - Following the publication of an article by Hunterbrook Media on January 29, 2026, which denied any partnership with Microsoft, Richtech Robotics' Class B stock price fell by over 29% within two trading days [4]. Group 2: Lead Plaintiff Process - Investors who purchased Richtech Robotics securities during the class period can seek to be appointed as lead plaintiff, representing the interests of all class members [5]. - The lead plaintiff is typically the investor with the greatest financial interest in the case and can choose a law firm to represent the class [5]. Group 3: Company Background - Richtech Robotics develops and sells robotic solutions for automation in the service industry [2].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, titled West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation, et al., No. 1:25-cv-10251 [3]. - Investors have until February 9, 2026, to request to be appointed to lead the case [3]. Group 2: Company Background - Integer Holdings Corporation designs and manufactures cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. - The company had previously claimed strong sales growth and market position for its electrophysiology devices, which is now being challenged [4]. Group 3: Financial Performance - Integer's stock price dropped by $35.22 per share, or over 32%, from $109.11 on October 22, 2025, to $73.89 on October 23, 2025, following the announcement of lowered sales guidance [6]. - The revised sales guidance for 2025 was adjusted to a range of $1.840 billion to $1.854 billion, down from $1.850 billion to $1.876 billion, which was below analysts' expectations [6]. - The company projected poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026, citing slower adoption of two of its electrophysiology devices [6][5].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [3]. Group 2: Allegations Against Ardent Health - Ardent Health operates acute care hospitals and healthcare facilities, with a critical focus on the collection of accounts receivable [4]. - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections" while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health disclosed a $43 million decrease in revenue for the quarter and a $54 million increase in professional liability reserves due to adverse claims developments [5]. - Following this announcement, Ardent Health's stock price fell by $4.75 per share, a decline of over 33%, from $14.05 to $9.30 per share [5].

Core Viewpoint - Carvana Co. is under investigation for potential violations of federal securities laws due to significant stock price drops linked to claims of accounting improprieties [1][2]. Group 1: Investigation Details - Bleichmar Fonti & Auld LLP is leading the investigation into Carvana for possible overstated earnings and improper accounting of related party transactions [3]. - The investigation follows a report by Gotham City Research LLC, which claims that Carvana's financial results are closely tied to related party entities controlled by Ernest Garcia II, indicating potential accounting irregularities [4]. Group 2: Stock Performance - Carvana's stock price fell over 20% on January 28, 2026, dropping from $474.06 per share to a low of $374.55 per share following the release of the Gotham City report [5]. - The report alleges that hidden relationships within Carvana's financial structure may have overstated earnings by over $1 billion, posing substantial risks to investors [4].